USPTO serial 88272871
KINOMICA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 15, 2020
- Examiner
- TRATOS, MARK STEVEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with KINOMICA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,144*
Plus Government fees of $2,550
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
London, GB
Macclesfield, Cheshire, GB
Macclesfield, Cheshire, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew D. Price
Andrew D. Price VENABLE LLPPO BOX 34385WASHINGTON, DC 20043-9998UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Scientific instruments and equipment, namely, diagnostic assays for measuring and analyzing proteins, enzymes, genes and tumors other than for medical or veterinary use | ACTIVE | — |
| 005 | Scientific instruments and equipment, namely, medical diagnostic assays for measuring and analyzing proteins, enzymes, genes and tumors | ACTIVE | — |
| 009 | Scientific instruments and equipment, namely, scientific equipment in the nature of mass spectrometers and liquid chromatography equipment, namely, chromatography columns for laboratory use for measuring and analyzing proteins, enzymes, genes and tumors; downloadable databases in the field of proteins, enzymes, genes, tumors, bioinformatics and drug efficacy; downloadable software for scientific, medical, healthcare, pharmaceutical and biotechnology analysis, namely, software for the identification, cataloguing, characterizing and analysis of data relating to proteins, enzymes, genes, tumors, bioinformatics and drug efficacy | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, research services in the field of protein, enzyme, gene and tumor analysis, design of research programmes and studies relating to protein, enzyme, gene and tumor analysis; medical research; medical development, namely, medicine development services; pharmaceutical and biotechnology research and development; design and development of computer software; providing temporary use of online, non-downloadable software for the identification, cataloguing, characterizing and analysis of data relating to proteins, enzymes, genes, tumors, bioinformatics and drug efficacy; proteomics, namely, medical and scientific research in the field of proteomes; kinase profiling and screening in the nature of testing of enzymes for scientific and medical research purposes; biomarker profiling and screening in the nature of testing of naturally occurring molecules, genes, or characteristics in the human body for scientific and medical research purposes; tumor testing and profiling, namely, diagnostic tests in the field of tumor identification and analysis for medical research purposes; gene expression profiling and analysis for medical research purposes; sequencing DNA and analysis for medical research purposes; genotyping for medical research and analysis purposes; contract scientific, medical, pharmaceutical and biotechnology research and laboratory services; providing an online, searchable database featuring medical research data relating to the identification, cataloguing, characterizing and analysis of proteins, enzymes, genes, tumors, bioinformatics and drug efficacy; providing temporary use of online, non-downloadable software for scientific, medical, healthcare, pharmaceutical and biotechnology analysis, namely, software for the identification, cataloguing, characterizing and analysis of data relating to proteins, enzymes, genes, tumors, bioinformatics and drug efficacy | ACTIVE | — |
| 044 | Medical services; healthcare services; medical screening; medical diagnostic services; providing an online, searchable database featuring data relating to the identification, cataloguing, characterizing and analysis of proteins, enzymes, genes, tumors, bioinformatics and drug efficacy; tumor testing and profiling, namely, tumor DNA sequencing and analysis for medical diagnostic purposes; gene expression profiling for medical diagnostic purposes; sequencing DNA for medical diagnostic purposes; tumor testing and profiling, namely, medical testing in the field of tumor identification, analysis and treatment; tumor testing and profiling, namely, diagnostic testing in the field of tumor treatment; gene expression profiling for medical diagnostic analysis purposes; sequencing DNA for medical diagnostic analysis purposes; providing an online, searchable database featuring patient data used in the treatment of individuals relating to the identification, cataloguing, characterizing and analysis of proteins, enzymes, genes, tumors, bioinformatics and drug efficacy | ACTIVE | — |
| 045 | Licensing of intellectual property | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Kinomica Limited
- Other trademarks owned by Kinomica Limited
- Other trademarks owned by Kinomica Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named KINOMICA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 15, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 15, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 20, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 20, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 20, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 30, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 30, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 10, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 23, 2020 | EXPT | EXPARTE APPEAL TERMINATED | — |
| May 22, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 20, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 20, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 20, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 20, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 14, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 14, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 13, 2020 | ALIE | ASSIGNED TO LIE | — |
| May 10, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 10, 2020 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| May 10, 2020 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| May 10, 2020 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Nov 13, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 13, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 13, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 18, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 18, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 11, 2019 | ALIE | ASSIGNED TO LIE | — |
| Oct 7, 2019 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Oct 7, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 5, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 4, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 4, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 5, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 4, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 14, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 26, 2019 | NWAP | NEW APPLICATION ENTERED | — |